WS/T 236-2017 in English

VALID

Genital herpes diagnosis

Issued on:2017-07-24
Implemented on:2018-02-01
File Format:PDF
Delivery:Via email within 2~4 business days

Price(USD)： $379.00
$368.00

Standard No:	WS/T 236-2017
Document status:	VALID
Title in English:	Genital herpes diagnosis
Title in Chinese:	生殖器疱疹诊断
Language:	English
File Format:	Electronic (PDF)
Delivery:	Via email within 2~4 business days
Issued on:	2017-07-24
Implemented on:	2018-02-01
Chinese Classification:	C59-
Professional Classification:	WS-Hygiene

Introduction

Core changes in the standard revision

Dimensions	WS 236-2003	WS/T 236-2017
Nature of the standard	Mandatory standard	Recommended standard
Diagnostic methods	Viral culture + cytology examination	New nucleic acid test + antibody test
Clinical manifestations	Unclassified	Refine the primary (primary/non-primary)

Analysis of Key Technical Points

1. Optimization of Diagnostic Pathway

The new standard establishes a three-level diagnostic system:
① Epidemiological history (history of unsafe sexual behavior) → ② Clinical manifestations (characteristic skin lesions) → ③ Laboratory confirmation (choose one of four types of detection methods)

2. Comparison of Laboratory Testing Methods

Detection Method	Sensitivity	Specificity	Reporting Time
Viral Culture	20-90%	100%	3-7 days
Antigen test	70-90%	95%	4 hours
Nucleic acid test	95%	98%	2 hours

Clinical implementation recommendations

Typical case handling process

Case: A 28-year-old male had clustered blisters on his foreskin for 3 days and had a history of unsafe sex 1 week ago.
Diagnostic steps:
1. Collect blister fluid for real-time fluorescence PCR testing (Appendix C method is preferred)
2. Simultaneously draw blood for HSV-2 specific antibody testing (Appendix D)
3. A positive PCR result confirms the diagnosis; a negative result but a positive antibody result can assist in the diagnosis

Precautions for special populations

Pregnant women: HSV-2 antibody screening is mandatory, and primary infection requires enhanced mother-to-child transmission prevention
HIV-infected individuals: Nucleic acid testing is recommended to avoid false negatives caused by immunosuppression

More samples: JJG 21-2008 JGJ 94-2008 DL/T 368-2010

Sample only — not a preview of WS/T 236-2017